ACP
GALT icon

Argyle Capital Partners’s Galectin Therapeutics GALT Stock Holding History

Argyle Capital Partners’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$28.2K Hold
13,375
– – 0.02% 150
2025
Q1 		$16.3K Hold
13,375
– – 0.01% 138
2024
Q4 		$17.3K Buy
+13,375
New +$17.3K 0.01% 141